Patent · US Active

Anti-Fc-gamma receptor IIB antibodies and uses thereof

US10407499B2 · kind B2 · utility

1Cited by
3References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 13, 2014
Grant dateSep 10, 2019
Priority date
Expiry dateMay 21, 2035

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides an anti-FcyRIIB antibodies which, in comparison to prior art antibodies, markedly increase ITIM phosphorylation of FcyRIIB and can thus be used for the treatment or prophylaxis of autoimmune diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.